Institution
Harvard University
Education•Cambridge, Massachusetts, United States•
About: Harvard University is a education organization based out in Cambridge, Massachusetts, United States. It is known for research contribution in the topics: Population & Cancer. The organization has 208150 authors who have published 530388 publications receiving 38152182 citations. The organization is also known as: Harvard & University of Harvard.
Topics: Population, Cancer, Health care, Galaxy, Medicine
Papers published on a yearly basis
Papers
More filters
••
TL;DR: Assays of ten blood transfusions in the United States that resulted in chronic NANBH revealed that there was at least one positive blood donor in nine of these cases and that all ten recipients seroconverted during their illnesses.
Abstract: A specific assay has been developed for a blood-borne non-A, non-B hepatitis (NANBH) virus in which a polypeptide synthesized in recombinant yeast clones of the hepatitis C virus (HCV) is used to capture circulating viral antibodies. HCV antibodies were detected in six of seven human sera that were shown previously to transmit NANBH to chimpanzees. Assays of ten blood transfusions in the United States that resulted in chronic NANBH revealed that there was at least one positive blood donor in nine of these cases and that all ten recipients seroconverted during their illnesses. About 80 percent of chronic, post-transfusion NANBH (PT-NANBH) patients from Italy and Japan had circulating HCV antibody; a much lower frequency (15 percent) was observed in acute, resolving infections. In addition, 58 percent of NANBH patients from the United States with no identifiable source of parenteral exposure to the virus were also positive for HCV antibody. These data indicate that HCV is a major cause of NANBH throughout the world.
3,198 citations
••
Institut Gustave Roussy1, University of California, San Francisco2, Harvard University3, University of Sydney4, Memorial Sloan Kettering Cancer Center5, Kolling Institute of Medical Research6, Mayo Clinic7, University of South Florida8, University of Pennsylvania9, University of Pittsburgh10, Princess Margaret Cancer Centre11, Merck & Co.12, University of California, Los Angeles13
TL;DR: In patients with advanced melanoma, including those who had had disease progression while they had been receiving ipilimumab, treatment with lambrolizumab resulted in a high rate of sustained tumor regression, with mainly grade 1 or 2 toxic effects.
Abstract: A b s t r ac t Background The programmed death 1 (PD-1) receptor is a negative regulator of T-cell effector mechanisms that limits immune responses against cancer. We tested the anti–PD-1 antibody lambrolizumab (previously known as MK-3475) in patients with advanced melanoma. Methods We administered lambrolizumab intravenously at a dose of 10 mg per kilogram of body weight every 2 or 3 weeks or 2 mg per kilogram every 3 weeks in patients with advanced melanoma, both those who had received prior treatment with the immune checkpoint inhibitor ipilimumab and those who had not. Tumor responses were assessed every 12 weeks. Results A total of 135 patients with advanced melanoma were treated. Common adverse events attributed to treatment were fatigue, rash, pruritus, and diarrhea; most of the adverse events were low grade. The confirmed response rate across all dose cohorts, evaluated by central radiologic review according to the Response Evaluation Criteria in Solid Tumors (RECIST), version 1.1, was 38% (95% confidence interval [CI], 25 to 44), with the highest confirmed response rate observed in the cohort that received 10 mg per kilogram every 2 weeks (52%; 95% CI, 38 to 66). The response rate did not differ significantly between patients who had received prior ipilimumab treatment and those who had not (confirmed response rate, 38% [95% CI, 23 to 55] and 37% [95% CI, 26 to 49], respectively). Responses were durable in the majority of patients (median follow-up, 11 months among patients who had a response); 81% of the patients who had a response (42 of 52) were still receiving treatment at the time of analysis in March 2013. The overall median progression-free survival among the 135 patients was longer than 7 months. Conclusions In patients with advanced melanoma, including those who had had disease progression while they had been receiving ipilimumab, treatment with lambrolizumab resulted in a high rate of sustained tumor regression, with mainly grade 1 or 2 toxic effects. (Funded by Merck Sharp and Dohme; ClinicalTrials.gov number, NCT01295827.)
3,195 citations
••
TL;DR: In this paper, the authors used contact angles and optical ellipsometry to study the kinetics of adsorption of monolayer films and to examine the experimental conditions necessary for the formation of high-quality films.
Abstract: : Long-chain alkanethiols, HS(CH2)nX, adsorb from solution onto gold surfaces and form ordered, oriented monolayer films. The properties of the interfaces between the films and liquids are largely independent of chain length when n > 10; in particular, wetting is not directly influenced by the proximity of the underlying gold substrate. The specific interaction of gold with sulfur and other soft nucleophiles and its low reactivity toward most hard acids and bases make it possible to vary the structure of the terminal group, X, widely and thus permit the introduction of a great range of functional groups into a surface. Studies of wettability of these monolayers, and of their composition using X-ray photoelectron spectroscopy (XPS), indicate that the monolayers are oriented with the tail group, X, exposed at the monolayer-air or monolayer- liquid interface. The adsorption of simple n-alkanethiols generates hydrophobic surfaces whose free energy (19 mJ/sq. m) is the lowest of any hydrocarbon surface studied to date. Measurement of contact angles is a useful tool for studying the structure and chemistry of the outermost few angstroms of a surface. This work used contact angles and optical ellipsometry to study the kinetics of adsorption of monolayer films and to examine the experimental conditions necessary for the formation of high-quality films.
3,193 citations
•
TL;DR: In recent years, the concept of boundaries has been at the center of influential research agendas in anthropology, history, political science, social psychology, and sociology, particularly concerning the study of relational processes as mentioned in this paper.
Abstract: In recent years, the concept of boundaries has been at the center of influential research agendas in anthropology, history, political science, social psychology, and sociology. This article surveys some of these developments while describing the value added provided by the concept, particularly concerning the study of relational processes. It discusses literatures on (a) social and collective identity; (b) class, ethnic/racial, and gender/sex inequality; (c) professions, knowledge, and science; and (d) communities, national identities, and spatial boundaries. It points to similar processes at work across a range of institutions and social locations. It also suggests paths for further developments, focusing on the relationship between social and symbolic boundaries, cultural mechanisms for the production of boundaries, difference and hybridity, and cultural membership and group classifications.
3,190 citations
••
TL;DR: In this article, the application of self-organizing maps, a type of mathematical cluster analysis that is particularly well suited for recognizing and classifying features in complex, multidi-mensional data, is described.
Abstract: Array technologies have made it straightfor- ward to monitor simultaneously the expression pattern of thousands of genes. The challenge now is to interpret such massive data sets. The first step is to extract the fundamental patterns of gene expression inherent in the data. This paper describes the application of self-organizing maps, a type of mathematical cluster analysis that is particularly well suited for recognizing and classifying features in complex, multidi- mensional data. The method has been implemented in a publicly available computer package, GENECLUSTER, that per- forms the analytical calculations and provides easy data visualization. To illustrate the value of such analysis, the approach is applied to hematopoietic differentiation in four well studied models (HL-60, U937, Jurkat, and NB4 cells). Expression patterns of some 6,000 human genes were assayed, and an online database was created. GENECLUSTER was used to organize the genes into biologically relevant clusters that suggest novel hypotheses about hematopoietic differentia- tion—for example, highlighting certain genes and pathways involved in ''differentiation therapy'' used in the treatment of acute promyelocytic leukemia.
3,186 citations
Authors
Showing all 209304 results
Name | H-index | Papers | Citations |
---|---|---|---|
Walter C. Willett | 334 | 2399 | 413322 |
Eric S. Lander | 301 | 826 | 525976 |
Robert Langer | 281 | 2324 | 326306 |
Meir J. Stampfer | 277 | 1414 | 283776 |
Ronald C. Kessler | 274 | 1332 | 328983 |
JoAnn E. Manson | 270 | 1819 | 258509 |
Albert Hofman | 267 | 2530 | 321405 |
Graham A. Colditz | 261 | 1542 | 256034 |
Frank B. Hu | 250 | 1675 | 253464 |
Bert Vogelstein | 247 | 757 | 332094 |
George M. Whitesides | 240 | 1739 | 269833 |
Paul M. Ridker | 233 | 1242 | 245097 |
Richard A. Flavell | 231 | 1328 | 205119 |
Eugene Braunwald | 230 | 1711 | 264576 |
Ralph B. D'Agostino | 226 | 1287 | 229636 |